494 related articles for article (PubMed ID: 17889119)
1. Risk factors and prognosis for proteinuria in renal transplant recipients.
Sancho A; Gavela E; Avila A; Morales A; Fernández-Nájera JE; Crespo JF; Pallardo LM
Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
[TBL] [Abstract][Full Text] [Related]
2. Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survival.
Sancho Calabuig A; Pallardó Mateu LM; Avila Bernabeu AI; Gavela Martínez E; Beltrán Catalán S; Crespo Albiach JF
Transplant Proc; 2009; 41(6):2122-5. PubMed ID: 19715850
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
Ibis A; Akgül A; Ozdemir N; Colak T; Sezer S; Arat Z; Haberal M
Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.
Gutiérrez MJ; González E; Andrés A; Morales JM
Transplant Proc; 2009; 41(6):2348-50. PubMed ID: 19715916
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
6. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation.
Fernández-Fresnedo G; Plaza JJ; Sánchez-Plumed J; Sanz-Guajardo A; Palomar-Fontanet R; Arias M
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii47-51. PubMed ID: 15192136
[TBL] [Abstract][Full Text] [Related]
7. Effect of overweight on kidney transplantation outcome.
Sancho A; Avila A; Gavela E; Beltrán S; Fernández-Nájera JE; Molina P; Crespo JF; Pallardó LM
Transplant Proc; 2007 Sep; 39(7):2202-4. PubMed ID: 17889137
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
[TBL] [Abstract][Full Text] [Related]
9. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome is related to long-term graft function in renal transplant recipients.
Ozdemir FN; Karakan S; Akgul A; Haberal M
Transplant Proc; 2009 Sep; 41(7):2808-10. PubMed ID: 19765441
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria after conversion to sirolimus in renal transplant recipients.
Sahin GM; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
[TBL] [Abstract][Full Text] [Related]
13. Early assessment of renal resistance index after kidney transplant can help predict long-term renal function.
Saracino A; Santarsia G; Latorraca A; Gaudiano V
Nephrol Dial Transplant; 2006 Oct; 21(10):2916-20. PubMed ID: 16891640
[TBL] [Abstract][Full Text] [Related]
14. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
Pazik J; Baczkowska T; Lewandowski Z; Lewandowska D; Ostrowska J; Perkowska Ptasińska A; Mróz A; Miszewska-Szyszkowska D; Rowinski W; Durlik M
Transplant Proc; 2006; 38(1):112-4. PubMed ID: 16504678
[TBL] [Abstract][Full Text] [Related]
17. Renal allograft protection with early angiotensin-converting enzyme inhibitors administration.
Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
Transplant Proc; 2004 Apr; 36(3):692-4. PubMed ID: 15110633
[TBL] [Abstract][Full Text] [Related]
18. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
Montanaro D; Gropuzzo M; Tulissi P; Vallone C; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
Transplant Proc; 2005 Mar; 37(2):991-3. PubMed ID: 15848600
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
